Vazobral, tablets, 30 pcs.

Combination drug.

a-Dihydroergocriptine is a dihydrogenated derivative of ergot alkaloid, blocks a1- and a2-adrenoreceptors. It has dopaminergic and serotoninergic effects, reduces platelet and erythrocyte aggregation, decreases vascular wall permeability, increases the number of functioning capillaries, improves blood circulation and metabolic processes in the brain, increases resistance of brain tissue to hypoxia.

Indications

Active ingredient

Composition

1 tablet contains:

the active ingredients:

dihydroergocriptine a-mesylate – 4.0 mg

caffeine – 40.00 mg;

auxiliates:

Lactose monohydrate – 94.1 mg,

Microcrystalline cellulose (Avicel PH102) – 60.0 mg,

magnesium stearate – 1.5 mg,

anhydrous colloidal silicon dioxide (Aerosil 200) – 0.4 mg.

How to take, the dosage

Interaction

Special Instructions

Contraindications

Side effects

Overdose

Pregnancy use

There are no clinical data on the use of Vazobral during pregnancy and lactation.

The use of the drug during breastfeeding may decrease lactation.